Connectionists: Connectionist : Neuromodulation by Digital and Analogue Drugs in Consciousness Research

[Axel Hutt]

Dear all, 

a final deadline extension to February 1, 2023 applies to the Frontiers Research Topic 

############################################################### 
Neuromodulation by Digital and Analogue Drugs in Consciousness Research 
############################################################### 

web site: https://www.frontiersin.org/research-topics/29684/neuromodulation-by-digital-and-analogue-drugs-in-consciousness-research 

Neuromodulation attracts increasing attention in today’s pre-clinical and clinical practice. 
It includes diverse medical procedures such as neurostimulation, general anesthesia, 
or drug treatments for mental disorders. These procedures are known to affect and even 
control the patient’s state of consciousness. Stimulations generated externally by electronic 
devices are known as Digital Drugs. Conversely, chemical and thus non-digital drugs are 
important elements in medical treatment of, e.g. mental disorders. Moreover, they serve 
as general anesthetics in todays' hospital practice, reversibly impairing the level of consciousness 
to allow surgery to occur. Interestingly, in certain cases, their neural actions resemble Digital 
Drug actions, although their origin and neurophysiological action is different. By virtue of both 
their similarity and difference to Digital Drugs, we call them Analogue Drugs. Well-known pairs 
of Digital and Analogue Drugs are visual flicker and psychedelic drugs (which both induce 
hallucinations) and isochronic auditory beats and anesthetics (with both inducing sedation). 

This Research Topic aims to address recent theoretical and experimental advances in 
neuromodulation of consciousness by Digital and Analogue Drugs. The theoretical and 
experimental studies represent a good overview of the current state of research in the 
respective research branch and may provide a deeper insight into the corresponding 
underlying neural action. This issue attempts to cover diverse types of (but not limited to) 
neurostimulation, general anesthesia, and drug treatment of mental disorders. 

Guest Editors: 
D. Hight, University Hospital Bern, Switzerland 
A. Hudetz, University of Michigan, USA 
A. Hutt, INRIA Nancy Grand Est, France 



-- 
Axel Hutt 
Directeur de Recherche 
Equipe MIMESIS 
INRIA Nancy Grand Est 
Bâtiment IHU 
1, Place de l'Hopital 
67000 Strasbourg, France 
https://mimesis.inria.fr/members/axel-hutt/ 
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mailman.srv.cs.cmu.edu/pipermail/connectionists/attachments/20221025/67f1837d/attachment.html>